Featured

Treatment of Co-Occurring Methamphetamine and Opioid Use Disorders



Published
Presented By: Mariah M. Kalmin, PhD

Speaker Biography: Dr. Kalmin received her PhD in epidemiology from George Washington University in 2017. She completed a postdoctoral research fellowship at the University of North Carolina’s Department of Epidemiology before joining the UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine. Dr. Kalmin is an infectious disease epidemiologist and UCLA Assistant Research Professor with advanced training in causal inference methodology along with practical experience coordinating clinical research studies at Johns Hopkins and George Washington Universities and current leadership as PI/PD of several projects at UCLA.

Webinar: Treatment of Co-Occurring Methamphetamine and Opioid Use Disorders

Webinar Abstract: Stimulants are the drivers of the fourth wave of the US drug overdose epidemic. Although most national attention and resources have been targeted at combating opioid use due to the surge of deaths related to fentanyl, recent reports suggest populations that use opioids are also using methamphetamine (MA) at high rates. Indeed, current data show that as many opioid overdose deaths involved psychostimulants as did not. These epidemiological data underscore the significance of developing efficacious treatments for methamphetamine use disorder (MUD) – especially in the setting of ongoing opioid use. Most therapeutic trials for MUD have failed with a few exceptions. Two randomized controlled trials (RCTs) showed that 30 mg of mirtazapine reduced MA use by 27% at week 36. A recent RCT completed by the clinical trials network (CTN) tested injectable naltrexone plus high-dose oral bupropion 450 mg/day compared to placebo and reported statistically significant reductions in methamphetamine use in a broad sample of people with MUD.

Earn PACE Credits:
1. Make sure you’re a registered member of LabRoots https://www.labroots.com/virtual-event/opioid-crisis-2021/agenda
2. Watch the webinar on YouTube or on the LabRoots Website https://www.labroots.com/webinar/treatment-co-occurring-methamphetamine-opioid-disorders
3. Click Here to get your PACE credits (Expiration date – November 03, 2023): https://www.labroots.com/credit/pace-credits/6863/third-party

LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
Category
Health
Be the first to comment